Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 57.45x is 132% above its 5-year average of -178.65x, near the high end of its 5-year range (-779.13x–57.45x).
As of the fiscal period ended Tuesday, June 30, 2026. 122.54% above its 12-month average of -254.88x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): 57.45x.
INTEREST COVERAGE RATIO
57.45x
INTEREST COVERAGE RATIO AVG TTM
-254.88x
INTEREST COVERAGE RATIO AVG 3Y
-254.88x
INTEREST COVERAGE RATIO AVG 5Y
-178.65x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+122.54%
CURRENT VS 3Y AVG
+122.54%
CURRENT VS 5Y AVG
+132.16%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.63x
median of 452 covered companies
CURRENT VS SECTOR MEDIAN
+1119.60%
vs the sector median at left
IceCure Medical Ltd
Market Cap
$3.11M
Interest Coverage Ratio
57.45x
TTM Avg
-254.88x
3Y Avg
-254.88x
5Y Avg
-178.65x
Market Cap
$3.07M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.04M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.00M
Interest Coverage Ratio
-7.53x
TTM Avg
56.70x
3Y Avg
56.70x
5Y Avg
56.70x
Market Cap
$3.23M
Interest Coverage Ratio
-12.86x
TTM Avg
85.32x
3Y Avg
145.98x
5Y Avg
123.76x
Market Cap
$3.29M
Interest Coverage Ratio
-507.49x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.34M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.39M
Interest Coverage Ratio
-0.25x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IceCure Medical Ltd (ICCM) | $3.11M | 57.45x | -254.88x | -254.88x | -178.65x |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.07M | N/A | N/A | N/A | N/A |
| MBody AI Ltd. (MBAI)vs › | $3.17M | -12.83x | N/A | N/A | N/A |
| Revelation Biosciences, Inc. (REVB)vs › | $3.04M | N/A | N/A | N/A | N/A |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.00M | -7.53x | 56.70x | 56.70x | 56.70x |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.23M | -12.86x | 85.32x | 145.98x | 123.76x |
| Aethlon Medical, Inc. (AEMD)vs › | $3.29M | -507.49x | N/A | N/A | N/A |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.34M | N/A | N/A | N/A | N/A |
| Moolec Science S.A. (MLEC)vs › | $3.39M | -0.25x | N/A | N/A | N/A |
| Evogene Ltd. (EVGN)vs › | $3.41M | -7.42x | N/A | N/A | N/A |
Interest Coverage
57.5x
Debt/Equity
0.01
Current Ratio
2.87
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 57.45x |
| 2026-03-31 | -157.30x |
| 2025-12-31 | -140.53x |
| 2025-09-30 | -779.13x |
| 2022-12-31 | -196.60x |
| 2022-06-30 | -17.84x |
| 2022-03-31 | -201.14x |
| 2021-12-31 | -97.75x |
| 2021-09-30 | -75.00x |
| 2021-03-31 | -6.70x |
